Extendicare (EXE) Stock Statistics & Valuation Metrics

Extendicare has a market cap or net worth of C$3.05B. The enterprise value is C$3.94K.

Extendicare has 95,046,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Extendicare’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 13.59%.

The current PE Ratio of Extendicare is 24.4. Extendicare’s PEG ratio is 1.15.

In the last 12 months, Extendicare had revenue of 1.66B and earned 96.66M in profits. Earnings per share was 1.13.

In the last 12 months, operating cash flow was 149.51M and capital expenditures -90.40M, giving a free cash flow of 59.11M billion.

Extendicare pays an annual dividend of C$0.044, resulting in a dividend yield of 1.59%

Extendicare upcoming earnings date is Nov 5, 2026, After Close (Confirmed).

Extendicare as a current ratio of 1.37, with Debt / Equity ratio of 159.54%

In the past 12 months, Extendicare has paid 33.45M in taxes.

Extendicare EV to EBITDA ratio is 10.35, with an EV/FCF ratio of 28.66.

Extendicare has C$93.47M in cash and marketable securities with C$645.75M in debt, giving a net cash position of -C$552.28M billion.

Gross margin is 39.48%, with operating margin of 8.33%, and net profit margin of 5.82%.

The average price target for Extendicare is C$38.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy